-
Product Insights
New![]()
BP Alternative Energy Investments_INTOG
BP Alternative Energy Investments_INTOG is an offshore wind project located in North Sea, United Kingdom. The project is owned and being developed by BP Plc. The project is expected to come online in 2028. Empower your strategies with our BP Alternative Energy Investments_INTOG report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
New![]()
Lightsource BP NSW Solar PV Park
Lightsource BP NSW Solar PV Park is a solar PV project located in New South Wales, Australia. The project is owned by Lightsource Renewable Energy Australia Pty Ltd and was developed by Lightsource BP Renewable Energy Investments Ltd. The project came online in 2022. Empower your strategies with our Lightsource BP NSW Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within...
-
Product Insights
New![]()
BP Solar 1 Solar PV Park
BP Solar 1 Solar PV Park is a solar PV project located in Ninh Thuan, Vietnam. The project came online in 2019. Empower your strategies with our BP Solar 1 Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
New![]()
Lightsource Bp Sicily Solar PV Park
Lightsource Bp Sicily Solar PV Park is a solar PV project located in Sicily, Italy. The project is owned by Lightsource BP Renewable Energy Investments Ltd and is developed by EGI Sarl; Lightsource BP Renewable Energy Investments Ltd. The project is at the permitting stage. Empower your strategies with our Lightsource Bp Sicily Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered...
-
Product Insights
New![]()
BP Refinery Castellon Solar PV Park
BP Refinery Castellon Solar PV Park is a solar PV project located in Valencian Community, Spain. The project is owned and being developed by Iberdrola SA. The project is expected to come online in 2024. Empower your strategies with our BP Refinery Castellon Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding...
-
Product Insights
New![]()
Lightsource BP Birch solar PV Park
Lightsource BP Birch solar PV Park is a solar PV project located in Ohio, United States. The project is owned and being developed by Lightsource BP Renewable Energy Investments Ltd. The project is at the permitting stage. Empower your strategies with our Lightsource BP Birch solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Product Insights
New![]()
Lightsource BP Insun Portugal Solar PV Park
Lightsource BP Insun Portugal Solar PV Park is a solar PV project located in Portugal. The project is owned and being developed by Lightsource BP Renewable Energy Investments Ltd. The project is at the permitting stage. Empower your strategies with our Lightsource BP Insun Portugal Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the...
-
Company Insights
New![]()
Innovation and Patenting activity of BP Plc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of BP Plc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Company Insights
New![]()
Innovation and Patenting activity of Aker BP ASA Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Aker BP ASA Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.3656B in Fatigue
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BP-1.3656B in FatigueDrug Details:BP-1.3656B is under development for the treatment of central nervous system disorders including...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.7881 in Eosinophilic Esophagitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BP-1.7881 in Eosinophilic EsophagitisDrug Details:BPI-7881A is under development for the treatment of atopic dermatitis and eosinophilic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.4979 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1.4979 in Binge Eating Disorder Drug Details: BP-1.4979 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.4979 in Restless Legs Syndrome
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1.4979 in Restless Legs Syndrome Drug Details: BP-1.4979 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Mantle Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Mantle Cell Lymphoma Drug Details: BP-1002 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1.7881 in Atopic Dermatitis (Atopic Eczema)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BP-1.7881 in Atopic Dermatitis (Atopic Eczema)Drug Details:BPI-7881A is under development for the treatment of atopic dermatitis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-102 in Recurrent Glioblastoma Multiforme (GBM)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-102 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: BP-102 is under investigation for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Cutaneous T-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Cutaneous T-Cell Lymphoma Drug Details: BP-1002 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Relapsed Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Relapsed Acute Myeloid Leukemia Drug Details: BP-1002 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Refractory Acute Myeloid Leukemia Drug Details: BP-1002 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Peripheral T-Cell Lymphomas (PTCL)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Peripheral T-Cell Lymphomas (PTCL) Drug Details: BP-1002 is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.